Company / R&D Expense
DocGo Inc. R&D Expense History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$10.9M
FY2025
5-year range
$1.2M / $10.9M
FY2021-FY2025
Trend
+101.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $3M to $11M over the past 2 years.
Based on SEC 10-K filings.
$11M in FY2025 with a 3-year CAGR of +48.4%.
Improved from $3M to $11M over the past 2 years.
R&D Expense over time
Growth rates
- 3-Year CAGR
- +48.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +48.4%, indicating consistent growth.
- In FY2025, r&d expense increased 101.7% year-over-year.
- Lowest r&d expense in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 4.19 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $10.9M | +101.7% |
| FY2024 | $5.4M | +62.2% |
| FY2023 | $3.3M | +0.0% |
| FY2022 | $3.3M | +179.1% |
| FY2021 | $1.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026